How were Ortho Clinical Diagnostics' earnings last quarter?

Ortho Clinical Diagnostics Holdings plc (NASDAQ:OCDX) released its earnings results on Wednesday, November, 3rd. The company reported $0.21 earnings per share for the quarter, beating analysts' consensus estimates of $0.14 by $0.07. The firm earned $522.50 million during the quarter, compared to the consensus estimate of $485.36 million. Ortho Clinical Diagnostics had a negative net margin of 0.02% and a positive trailing twelve-month return on equity of 41.71%.

When did Ortho Clinical Diagnostics IPO?

Ortho Clinical Diagnostics (OCDX) raised $1.5 billion in an IPO on Thursday, January 28th 2021. The company issued 70,000,000 shares at a price of $20.00-$23.00 per share. J.P. Morgan, BofA Securities, Goldman Sachs, Barclays and Morgan Stanley acted as the underwriters for the IPO and Citigroup, Credit Suisse, UBS Investment Bank, Evercore ISI, Piper Sandler, ING, Macquarie Capital, Nomura, TCG Capital Markets, Drexel Hamilton, H.C. Wainwright & Co., Ramirez & Co. and Siebert Williams Shank were co-managers.

NASDAQ:OCDX

Ortho Clinical Diagnostics (OCDX) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Free OCDX Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: $17.63
▼
$17.63
50-Day Range: $17.63
▼
$17.63
52-Week Range: $16.04
▼
$22.99

Volume: 5,400 shs
Average Volume: 1.24 million shs
Market Capitalization: $3.92 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Ortho Clinical Diagnostics alerts:

Ad Stansberry Research

Strange new buyer driving up gold

One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."

But there's a much better move you can make to get in front of these big moves today.

About Ortho Clinical Diagnostics Stock (NASDAQ:OCDX)

Ortho Clinical Diagnostics Holdings plc provides in-vitro diagnostics solutions to the clinical laboratory and transfusion medicine communities worldwide. The company offers automated instruments; and assays, reagents, and other consumables that are used by these instruments to generate test results. Its solutions include clinical chemistry and immunoassay instruments and tests to detect and monitor disease progression across a spectrum of therapeutic areas, including COVID-19 antibody and antigen tests; and immunohematology instruments and tests for blood typing to ensure patient-donor compatibility in blood transfusions, as well as donor screening instruments and tests for blood and plasma screening for infectious diseases. The company is also involved in the provision of contract manufacturing and orthocare services. Its products are used in hospitals, laboratories, clinics, blood banks, and donor centers. Ortho Clinical Diagnostics Holdings plc was founded in 1939 and is headquartered in Raritan, New Jersey.

Ad Stansberry Research

Strange new buyer driving up gold

One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."

But there's a much better move you can make to get in front of these big moves today.

OCDX Stock News Headlines

August 22, 2023 | investing.com

Novacyt: Innovative Clinical Diagnostics

August 9, 2023 | cbsnews.com

First long COVID treatment clinical trials from NIH getting underway

April 19, 2024 | Stansberry Research (Ad)

Strange new buyer driving up gold

One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."

March 18, 2023 | finance.yahoo.com

Clinical Diagnostics Global Market Report 2023: Sector to Reach $124.7 Billion by 2028 at a CAGR of 8.56%

February 25, 2023 | marketwatch.com

Clinical Diagnostics Mass Spectrometry Market Brief Analysis By Top Leading Companies

February 25, 2023 | marketwatch.com

Clinical Diagnostics Market 2023 is FASTEST-GROWING in [ Medical Devices & Consumables ] Sector till 2028

February 22, 2023 | marketwatch.com

Clinical Diagnostics Market Size in 2023 Business Forecast 2028 by Discovering LATEST TRENDS

February 18, 2023 | seekingalpha.com

ChitogenX announces $3.5M grant to advance ORTHO-R commercial development

April 19, 2024 | Stansberry Research (Ad)

Strange new buyer driving up gold

One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."

January 25, 2023 | marketwatch.com

Clinical Diagnostics Mass Spectrometry Market 2023 : Future Developments, Key Vendors, Regional Analysis and Industry Scope by 2029

January 12, 2023 | finance.yahoo.com

The Worldwide Clinical Diagnostics Industry is Expected to Reach $93.6 Billion by 2027

November 2, 2022 | finance.yahoo.com

Dr. James S. Lewis II, Antibiotic Susceptibility Test Expert, Joins as Chair of Selux Diagnostics' Clinical Advisory Board

October 14, 2022 | finance.yahoo.com

Global Clinical Microbiology Instruments and Reagents Market Report 2022: Advancements in Molecular Diagnostics Drive Growth

September 23, 2022 | finance.yahoo.com

BrightInsight and bioMérieux Announce Partnership to Launch Clinical Digital Solutions for Diagnostics

May 7, 2022 | seekingalpha.com

Ortho Clinical Diagnostics Holdings PLC (OCDX) CEO Chris Smith on Q1 2022 Results - Earnings Call Transcript

May 5, 2022 | fool.com

Ortho Clinical Diagnostics Holdings plc (OCDX) Q1 2022 Earnings Call Transcript

May 5, 2022 | seekingalpha.com

Ortho Clinical Diagnostics Holdings plc 2022 Q1 - Results - Earnings Call Presentation

May 4, 2022 | finance.yahoo.com

Ortho Clinical Diagnostics (OCDX) Q1 Earnings Top Estimates

May 4, 2022 | seekingalpha.com

Ortho Clinical Diagnostics Non-GAAP EPS of $0.23 beats by $0.03, revenue of $495M misses by $12.41M

May 4, 2022 | finance.yahoo.com

Ortho Clinical Diagnostics Reports First Quarter 2022 Results

April 28, 2022 | finance.yahoo.com

Why Ortho Clinical (OCDX) Could Beat Earnings Estimates Again

April 27, 2022 | finance.yahoo.com

Ortho Clinical Diagnostics (OCDX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

April 26, 2022 | finance.yahoo.com

Ortho Clinical Diagnostics Recognized with Fifth Prestigious Edison Award for Highly Accurate COVID-19 Solution

April 20, 2022 | finance.yahoo.com

Ortho Clinical Diagnostics to Report First Quarter 2022 Results on May 4, 2022

March 24, 2022 | finance.yahoo.com

Ortho Clinical (OCDX) Upgraded to Strong Buy: Here's What You Should Know

March 11, 2022 | finance.yahoo.com

Wall Street Analysts Predict a 58% Upside in Ortho Clinical (OCDX): Here's What You Should Know

March 9, 2022 | finance.yahoo.com

Ortho Clinical Diagnostics Wins Bronze Stevie® Award for Customer Service and Support

See More Headlines

Receive OCDX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ortho Clinical Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/03/2021
Today: 4/19/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Diagnostic Substances
Sub-Industry: N/A
Current Symbol: NASDAQ:OCDX
CUSIP: N/A
CIK: 1828443
Web: www.orthoclinicaldiagnostics.com
Phone: 908-218-8000
Fax: N/A
Employees: 4,800
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($0.01)
Trailing P/E Ratio: N/A
Forward P/E Ratio: 21.77
P/E Growth: 1.66
Net Income: $-54,300,000.00
Net Margins: -0.02%
Pretax Margin: 1.38%
Return on Equity: 41.71%
Return on Assets: 5.10%

Debt

Debt-to-Equity Ratio: 4.91
Current Ratio: 1.89
Quick Ratio: 1.29

Sales & Book Value

Annual Sales: $2.04 billion
Price / Sales: 1.92
Cash Flow: $2.28 per share
Price / Cash Flow: 7.73
Book Value: $1.99 per share
Price / Book: 8.86

Miscellaneous

Outstanding Shares: 222,585,000
Free Float: N/A
Market Cap: $3.92 billion
Optionable: Not Optionable
Beta: 1.32

These 7 Stocks Will Be Magnificent in 2024

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

Mr. Christopher Michael Smith (Age 59)
Chairman & CEO
Comp: $2.85M
Mr. Joseph M. Busky CPA (Age 54)
Chief Financial Officer
Comp: $607.06k
Mr. Michael A. Schlesinger (Age 63)
Exec. VP, Gen. Counsel & Sec.
Comp: $879.13k
Mr. Michael S. Iskra (Age 52)
Exec. VP of Commercial Excellence & Strategy
Comp: $760.23k
Dr. Chockalingam Palaniappan Ph.D. (Age 57)
Chief Innovation Officer
Comp: $826.63k
Ms. Ariane Schiereck
Chief Information Officer
Mr. Marwan Fathallah
Head of Quality, Regulatory, Compliance, Clinical, Medical & Scientific Affairs
Mr. Gary Passman
Head of People & Culture
Karen Taylor
Head of Global Commercial Enablement
Mr. Warren Stone
Head of Americas

Key Competitors

View All Competitors

OCDX Stock Analysis - Frequently Asked Questions

How were Ortho Clinical Diagnostics' earnings last quarter?: Ortho Clinical Diagnostics Holdings plc (NASDAQ:OCDX) released its earnings results on Wednesday, November, 3rd. The company reported $0.21 earnings per share for the quarter, beating analysts' consensus estimates of $0.14 by $0.07. The firm earned $522.50 million during the quarter, compared to the consensus estimate of $485.36 million. Ortho Clinical Diagnostics had a negative net margin of 0.02% and a positive trailing twelve-month return on equity of 41.71%.
When did Ortho Clinical Diagnostics IPO?: Ortho Clinical Diagnostics (OCDX) raised $1.5 billion in an IPO on Thursday, January 28th 2021. The company issued 70,000,000 shares at a price of $20.00-$23.00 per share. J.P. Morgan, BofA Securities, Goldman Sachs, Barclays and Morgan Stanley acted as the underwriters for the IPO and Citigroup, Credit Suisse, UBS Investment Bank, Evercore ISI, Piper Sandler, ING, Macquarie Capital, Nomura, TCG Capital Markets, Drexel Hamilton, H.C. Wainwright & Co., Ramirez & Co. and Siebert Williams Shank were co-managers.

This page (NASDAQ:OCDX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Ortho Clinical Diagnostics (OCDX) Stock Price, News & Analysis

About Ortho Clinical Diagnostics Stock (NASDAQ:OCDX)

OCDX Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

OCDX Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info